0001236030-24-000014.txt : 20240509
0001236030-24-000014.hdr.sgml : 20240509
20240509130710
ACCESSION NUMBER: 0001236030-24-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240509
DATE AS OF CHANGE: 20240509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRICHEP PATRICIA B
CENTRAL INDEX KEY: 0001236215
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 24929631
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD., SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-05-08
0
0000725363
CEL SCI CORP
CVM
0001236215
PRICHEP PATRICIA B
8229 BOONE BLVD., SUITE 802
VIENNA
VA
22182
0
1
0
0
Senior Vice President
0
Common Stock
2024-05-08
4
P
0
8000
1.39
A
232326
D
On May 8, 2024, Ms. Prichep purchased 8,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.
Patricia Prichep
2024-05-09